Explorer

Macleods Pharmaceuticals Files Draft Papers With Sebi For Rs 5,000-Cr IPO

The initial share-sale is entirely an offer-for-sale (OFS) of up to 6.05 crore equity shares by promoters, according to the draft red herring prospectus

New Delhi: Macleods Pharmaceuticals has filed preliminary papers with capital markets regulator Sebi to mop-up Rs 5,000 crore through an initial public offering (IPO).

The initial share-sale is entirely an offer-for-sale (OFS) of up to 6.05 crore equity shares by promoters, according to the draft red herring prospectus (DRHP).

According to the DRHP, a portion of the IPO would be reserved for subscription for eligible employees.

Since the public issue is an OFS, the selling shareholders will be entitled to the entire proceeds of the offer and the company will not receive any proceeds from the public issue.

According to merchant banking sources, the size of the IPO is expected to be Rs 5,000 crore.

Macleods is engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.

The company is present across regions in India, through its sales team that comprised more than 4,900 medical representatives in India as on September, 2021.

Further, it has an extensive global presence in more than 170 countries across developed and emerging markets such as North America, Europe, Africa, Asia, South America, and the Commonwealth of Independent States.

Macleods is wholly-owned by its promoter and promoter group, and has grown organically since inception through internal accruals, and without raising any external funding from private equity players.

Kotak Mahindra Capital Company, Citigroup Global Markets India, Edelweiss Financial Services, ICICI Securities, and Nomura Financial Advisory and Securities (India) Private Limited are the book running lead managers to the IPO.

In August 2021, Emcure Pharma had filed draft papers with Sebi for a proposed Rs 4,500 crore- Rs 5,000 crore initial share-sale.

View More
Advertisement
Advertisement
25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Advertisement

Top Headlines

'Rahul Gandhi Has His Opinion, I Have Mine': Supriya Sule Praises Savarkar
'Rahul Gandhi Has His Opinion, I Have Mine': Supriya Sule Praises Savarkar
Rahul Gandhi, Eknath Shinde's Choppers, Bags Checked In Maharashtra
Rahul Gandhi, Eknath Shinde's Choppers, Bags Checked In Maharashtra
'Expired Fire Dousers, Faulty Alarm System': Jhansi Hospital Tragedy Exposes Safety Lapses
'Expired Fire Dousers, Faulty Alarm System': Jhansi Hospital Tragedy Exposes Safety Lapses
Lawrence Bishnoi Plotted Baba Siddique Murder Within 10 Days Of Firing At Salman Khan's House
Lawrence Bishnoi Plotted Baba Siddique Murder Within 10 Days Of Firing At Salman Khan's House
Advertisement
ABP Premium

Videos

Jhansi Medical College Fire: Akhilesh Yadav Slams Yogi Govt, Demands Action as Tragic Fire Claims Lives of 10 NewbornsMaharashtra Elections 2024: Amit Shah Slams LoP Rahul Gandhi Ahead Of Polls | ABP NewsCM Yogi Announces Rs 5 Lakh Compensation for Jhansi Tragedy Victims' Families, Rs 50,000 for the InjuredDelhi Crime: Gunfire Erupts Again in Delhi, Criminals Open Fire in Gokulpuri Area

Photo Gallery

Embed widget